These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23865715)

  • 1. Folate-based near-infrared fluorescent theranostic gemcitabine delivery.
    Yang Z; Lee JH; Jeon HM; Han JH; Park N; He Y; Lee H; Hong KS; Kang C; Kim JS
    J Am Chem Soc; 2013 Aug; 135(31):11657-62. PubMed ID: 23865715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug.
    Maiti S; Park N; Han JH; Jeon HM; Lee JH; Bhuniya S; Kang C; Kim JS
    J Am Chem Soc; 2013 Mar; 135(11):4567-72. PubMed ID: 23461361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model.
    Paolino D; Licciardi M; Celia C; Giammona G; Fresta M; Cavallaro G
    Eur J Pharm Biopharm; 2012 Sep; 82(1):94-102. PubMed ID: 22705641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-gemcitabine: a new gemcitabine prodrug for treating cancer.
    Dasari M; Acharya AP; Kim D; Lee S; Lee S; Rhea J; Molinaro R; Murthy N
    Bioconjug Chem; 2013 Jan; 24(1):4-8. PubMed ID: 23237198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Nanoparticles for Fluorescence Imaging of Folate Receptor Positive Tumors.
    Marko AJ; Borah BM; Siters KE; Missert JR; Gupta A; Pera P; Isaac-Lam MF; Pandey RK
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33317162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Responsive Micelles with Aggregation-Induced Emission Feature and Two-Photon Aborsption for Accurate Drug Delivery and Bioimaging.
    Yu T; Zhuang W; Su X; Ma B; Hu J; He H; Li G; Wang Y
    Bioconjug Chem; 2019 Jul; 30(7):2075-2087. PubMed ID: 31260272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway.
    Bildstein L; Dubernet C; Marsaud V; Chacun H; Nicolas V; Gueutin C; Sarasin A; Bénech H; Lepêtre-Mouelhi S; Desmaële D; Couvreur P
    J Control Release; 2010 Oct; 147(2):163-70. PubMed ID: 20691740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
    Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
    Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine-loaded Folic Acid Tagged Liposomes: Improved Pharmacokinetic and Biodistribution Profile.
    Unnam S; Panduragaiah VM; Sidramappa MA; Muddana Eswara BR
    Curr Drug Deliv; 2019; 16(2):111-122. PubMed ID: 30360740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor.
    Wu JB; Shi C; Chu GC; Xu Q; Zhang Y; Li Q; Yu JS; Zhau HE; Chung LW
    Biomaterials; 2015 Oct; 67():1-10. PubMed ID: 26197410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A GPC1-targeted and gemcitabine-loaded biocompatible nanoplatform for pancreatic cancer multimodal imaging and therapy.
    Qiu W; Zhang H; Chen X; Song L; Cui W; Ren S; Wang Y; Guo K; Li D; Chen R; Wang Z
    Nanomedicine (Lond); 2019 Sep; 14(17):2339-2353. PubMed ID: 31414945
    [No Abstract]   [Full Text] [Related]  

  • 12. Just getting into cells is not enough: mechanisms underlying 4-(N)-stearoyl gemcitabine solid lipid nanoparticle's ability to overcome gemcitabine resistance caused by RRM1 overexpression.
    Wonganan P; Lansakara-P DS; Zhu S; Holzer M; Sandoval MA; Warthaka M; Cui Z
    J Control Release; 2013 Jul; 169(1-2):17-27. PubMed ID: 23570983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs.
    Licciardi M; Paolino D; Celia C; Giammona G; Cavallaro G; Fresta M
    Biomaterials; 2010 Oct; 31(28):7340-54. PubMed ID: 20609469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyanine-Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells.
    Jiang Z; Pflug K; Usama SM; Kuai D; Yan X; Sitcheran R; Burgess K
    J Med Chem; 2019 Oct; 62(20):9236-9245. PubMed ID: 31469566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine.
    Dubey RD; Alam N; Saneja A; Khare V; Kumar A; Vaidh S; Mahajan G; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Int J Pharm; 2015 Aug; 492(1-2):80-91. PubMed ID: 26165611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid.
    Pasut G; Canal F; Dalla Via L; Arpicco S; Veronese FM; Schiavon O
    J Control Release; 2008 May; 127(3):239-48. PubMed ID: 18346806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine Co-Encapsulated with Curcumin in Folate Decorated PLGA Nanoparticles; a Novel Approach to Treat Breast Adenocarcinoma.
    Mukhopadhyay R; Sen R; Paul B; Kazi J; Ganguly S; Debnath MC
    Pharm Res; 2020 Feb; 37(3):56. PubMed ID: 32072346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Loading Strategies to Improve Tumor Uptake of Gemcitabine in a Murine Orthotopic Bladder Cancer Model Using Ultrasound and Microbubbles.
    Ruan JL; Browning RJ; Yildiz YO; Bau L; Kamila S; Gray MD; Folkes L; Hampson A; McHale AP; Callan JF; Vojnovic B; Kiltie AE; Stride E
    Ultrasound Med Biol; 2021 Jun; 47(6):1596-1615. PubMed ID: 33707089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs.
    Immordino ML; Brusa P; Rocco F; Arpicco S; Ceruti M; Cattel L
    J Control Release; 2004 Dec; 100(3):331-46. PubMed ID: 15567500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate-Conjugated pH-Responsive Nanocarrier Designed for Active Tumor Targeting and Controlled Release of Gemcitabine.
    Pourjavadi A; Tehrani ZM; Moghanaki AA
    Pharm Res; 2016 Feb; 33(2):417-32. PubMed ID: 26438181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.